Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Functional Organotypic Cultures of Prostate Tissues: A Relevant Preclinical Model that Preserves Hypoxia Sensitivity and Calcium Signaling.

Figiel S, Pasqualin C, Bery F, Maupoil V, Vandier C, Potier-Cartereau M, Domingo I, Guibon R, Bruyere F, Maheo K, Fromont G.

Am J Pathol. 2019 Jun;189(6):1268-1275. doi: 10.1016/j.ajpath.2019.02.017. Epub 2019 Apr 5.

PMID:
30954471
2.

Fatty acid profile in peri-prostatic adipose tissue and prostate cancer aggressiveness in African-Caribbean and Caucasian patients.

Figiel S, Pinault M, Domingo I, Guimaraes C, Guibon R, Besson P, Tavernier E, Blanchet P, Multigner L, Bruyère F, Haillot O, Mathieu R, Vincendeau S, Rioux-Leclercq N, Lebdai S, Azzouzi AR, Perrouin-Verbe MA, Fournier G, Doucet L, Rigaud J, Renaudin K, Mahéo K, Fromont G.

Eur J Cancer. 2018 Mar;91:107-115. doi: 10.1016/j.ejca.2017.12.017.

PMID:
29413967
3.

Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment.

Dumas JF, Brisson L, Chevalier S, Mahéo K, Fromont G, Moussata D, Besson P, Roger S.

Semin Cancer Biol. 2017 Apr;43:90-110. doi: 10.1016/j.semcancer.2017.03.004. Epub 2017 Mar 18. Review.

PMID:
28323020
4.

ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.

Dartier J, Lemaitre E, Chourpa I, Goupille C, Servais S, Chevalier S, Mahéo K, Dumas JF.

Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1075-1084. doi: 10.1016/j.bbagen.2017.02.019. Epub 2017 Feb 16.

PMID:
28214549
5.

Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.

Figiel S, Vasseur C, Bruyere F, Rozet F, Maheo K, Fromont G.

Hum Pathol. 2017 Mar;61:26-32. doi: 10.1016/j.humpath.2016.10.013. Epub 2016 Nov 4.

PMID:
27818287
6.

Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.

Chauvin L, Goupille C, Blanc C, Pinault M, Domingo I, Guimaraes C, Bougnoux P, Chevalier S, Mahéo K.

Biochim Biophys Acta. 2016 Apr;1861(4):380-90. doi: 10.1016/j.bbalip.2016.01.012. Epub 2016 Jan 26.

PMID:
26821209
7.

PPARβ mRNA expression, reduced by n-3 PUFA diet in mammary tumor, controls breast cancer cell growth.

Wannous R, Bon E, Mahéo K, Goupille C, Chamouton J, Bougnoux P, Roger S, Besson P, Chevalier S.

Biochim Biophys Acta. 2013 Nov;1831(11):1618-25. doi: 10.1016/j.bbalip.2013.07.010. Epub 2013 Jul 30.

PMID:
23906790
8.

Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy.

Mahéo K, Chevalier S, Vibet S, Bougnoux P, Richard S, Serrière S, Bleuzen A, Tranquart F, Goupille C.

Breast Cancer Res Treat. 2012 Aug;134(3):1013-25. doi: 10.1007/s10549-012-2015-7. Epub 2012 Mar 22.

PMID:
22438047
9.

Reducing endothelial NOS activation and interstitial fluid pressure with n-3 PUFA offset tumor chemoresistance.

Kornfeld S, Goupille C, Vibet S, Chevalier S, Pinet A, Lebeau J, Tranquart F, Bougnoux P, Martel E, Maurin A, Richard S, Champeroux P, Mahéo K.

Carcinogenesis. 2012 Feb;33(2):260-7. doi: 10.1093/carcin/bgr274. Epub 2011 Nov 23.

PMID:
22114075
10.

Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth.

Bougnoux P, Hajjaji N, Maheo K, Couet C, Chevalier S.

Prog Lipid Res. 2010 Jan;49(1):76-86. doi: 10.1016/j.plipres.2009.08.003. Epub 2009 Aug 26. Review.

PMID:
19715726
11.

Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response.

Vibet S, Goupille C, Bougnoux P, Steghens JP, Goré J, Mahéo K.

Free Radic Biol Med. 2008 Apr 1;44(7):1483-91. doi: 10.1016/j.freeradbiomed.2008.01.009. Epub 2008 Jan 26.

PMID:
18267129
12.

Increased BRCA1 protein in mammary tumours of rats fed marine omega-3 fatty acids.

Jourdan ML, Mahéo K, Barascu A, Goupille C, De Latour MP, Bougnoux P, Rio PG.

Oncol Rep. 2007 Apr;17(4):713-9.

PMID:
17342305
13.

Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines.

Vibet S, Mahéo K, Goré J, Dubois P, Bougnoux P, Chourpa I.

Drug Metab Dispos. 2007 May;35(5):822-8. Epub 2007 Feb 12.

PMID:
17296624
14.

Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization.

Colas S, Mahéo K, Denis F, Goupille C, Hoinard C, Champeroux P, Tranquart F, Bougnoux P.

Clin Cancer Res. 2006 Oct 1;12(19):5879-86.

15.

Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.

Mahéo K, Vibet S, Steghens JP, Dartigeas C, Lehman M, Bougnoux P, Goré J.

Free Radic Biol Med. 2005 Sep 15;39(6):742-51.

PMID:
16109304
16.

Alpha-tocopherol suppresses mammary tumor sensitivity to anthracyclines in fish oil-fed rats.

Colas S, Germain E, Arab K, Maheo K, Goupille C, Bougnoux P.

Nutr Cancer. 2005;51(2):178-83.

PMID:
15860440
17.

Transcriptional induction of CYP1A1 by oltipraz in human Caco-2 cells is aryl hydrocarbon receptor- and calcium-dependent.

Le Ferrec E, Lagadic-Gossmann D, Rauch C, Bardiau C, Maheo K, Massiere F, Le Vee M, Guillouzo A, Morel F.

J Biol Chem. 2002 Jul 5;277(27):24780-7. Epub 2002 Apr 16.

18.

Differential effects of oltipraz on CYP1A and CYP2B in rat lung.

Le Ferrec E, Ilyin G, Mahéo K, Bardiau C, Courtois A, Guillouzo A, Morel F.

Carcinogenesis. 2001 Jan;22(1):49-55.

PMID:
11159740
19.

Endotoxin suppresses the oltipraz-mediated induction of major hepatic glutathione transferases and cytochromes P450 in the rat.

Mahéo K, Morel F, Antras-Ferry J, Langoüet S, Desmots F, Corcos L, Guillouzo A.

Hepatology. 1998 Dec;28(6):1655-62.

PMID:
9828231
20.

Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes.

Antras-Ferry J, Mahéo K, Chevanne M, Dubos MP, Morel F, Guillouzo A, Cillard P, Cillard J.

Carcinogenesis. 1997 Nov;18(11):2113-7.

PMID:
9395210
21.

Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes.

Mahéo K, Morel F, Langouët S, Kramer H, Le Ferrec E, Ketterer B, Guillouzo A.

Cancer Res. 1997 Sep 1;57(17):3649-52.

22.

The use of primary hepatocyte cultures for the evaluation of chemoprotective agents.

Morel F, Langouët S, Mahéo K, Guillouzo A.

Cell Biol Toxicol. 1997 Jul;13(4-5):323-9. Review.

PMID:
9298252
23.

Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture.

Langouët S, Mahéo K, Berthou F, Morel F, Lagadic-Gossman D, Glaise D, Coles B, Ketterer B, Guillouzo A.

Carcinogenesis. 1997 Jul;18(7):1343-9.

PMID:
9230277
24.

Modulation of glutathione S-transferase subunits A2, M1, and P1 expression by interleukin-1beta in rat hepatocytes in primary culture.

Maheo K, Antras-Ferry J, Morel F, Langouët S, Guillouzo A.

J Biol Chem. 1997 Jun 27;272(26):16125-32.

25.

Dexamethasone differently modulates TNF-alpha- and IL-1beta-induced transcription of the hepatic Mn-superoxide dismutase gene.

Antras-Ferry J, Mahéo K, Morel F, Guillouzo A, Cillard P, Cillard J.

FEBS Lett. 1997 Feb 10;403(1):100-4.

26.

Use of hepatocyte cultures for the study of hepatotoxic compounds.

Guillouzo A, Morel F, Langouët S, Maheo K, Rissel M.

J Hepatol. 1997;26 Suppl 2:73-80. Review.

PMID:
9204412
27.

Metabolism of aflatoxin B1 by human hepatocytes in primary culture.

Langouet S, Coles B, Morel F, Maheo K, Ketterer B, Guillouzo A.

Adv Exp Med Biol. 1996;387:439-42. No abstract available.

PMID:
8794238

Supplemental Content

Support Center